Paul Daruwala, President & CEO
Paul Daruwala has been President, CEO and Director of Cellics since October 2022. Previously he was COO and CCO of Cidara Therapeutics, from 2014 -2022. During his tenure, Cidara completed a successful IPO, advanced its founding preclinical program, rezafungin, to NDA filing, transitioned from a small molecule company to a biologics focused one, advanced its immunotherapeutic Cloudbreak platform from basic research into Phase 1, and established foundational partnerships with pharmaceutical and biotech companies. Prior to Cidara, over his 30 years in the biopharma field, Paul held executive roles in US and Global franchise leadership, business development and new product planning across Bristol Myers Squibb, Vertex Pharmaceuticals and Merck & Co. Daruwala has a depth and breadth of therapeutic experience across infectious disease, liver, GI, cardiovascular and respiratory diseases, hematology, pain, and arthritis and earned his degree in Pharmacy from the University of Kentucky.
Liangfang Zhang, Ph.D., Founder
Dr. Zhang is a Professor in the NanoEngineering Department and Moores Cancer Center at the University of California, San Diego (UCSD). Dr. Zhang directs the Laboratory of Nanomaterials and Nanomedicine at UCSD. His research is focused on creating cutting-edge biomimetic nanotechnologies and exploiting them for various biomedical applications with a particular focus on drug delivery, biodetoxification and vaccination. Dr. Zhang invented a novel cellular membrane coated nanoparticle technology for biodetoxificaiton and drug delivery. The “Nanosponge” technology developed by Dr. Zhang formed the fundamental platform for the launch of Cellics Therapetuics. Dr. Zhang has published 135 peer-reviewed articles and holds 51 issued/pending US and International patents. Dr. Zhang has received the American Chemical Society’s Victor K. LaMer Award in 2009, the Best Teacher Award from the Jacobs School of Engineering at UCSD in 2011, the American Chemical Society’s Unilever Award from in 2012, the MIT Technology Review’s TR35 Innovator Award in 2013, the American Institute of Chemical Engineers’ Allan P. Colburn Award in 2014, the Popular Science’s Brilliant 10 Award in 2016. In 2015 Dr. Zhang was elected to the College of the Fellows of the American Institute of Medical and Biological Engineering. Dr. Zhang holds B.E. and M.S. degrees in Chemical Engineering from Tsinghua University in China. He received his Ph.D. in Chemical Engineering from the University of Illinois at Urbana- Champaign (UIUC) in 2006, followed by a postdoctoral training at MIT. He joined the faculty at UCSD as Assistant Professor in July 2008 and was promoted to Associate Professor with tenure in March 2012, and to Professor in July 2014.